glp-1 dopamine Glucagon-like peptide 1 receptor activation regulates cocaine actions and homeostasis in the lateral septum by decreasing arachidonic acid levels GLP-1 was approved as a

A Shift in How We Approach Obesity The increased popularity of GLP-1 agonists is connected to changes in attitudes toward obesity

Both sleep length and quality are influenced by endocrine factors such as somatoliberin (growth hormone-releasing hormone),7 which contributes to slow-wave sleep8 an indicator of healthy slumber.9 Some research suggests, though not conclusively, that DSIP can stimulate somatoliberin secretion,10 thereby promoting the onset of a deep stage of sleep

Previous studies have revealed that migraine patients suffer from impaired insulin sensitivity and have higher blood glucose levels [28]

Glucagon-like peptide-1 (GLP-1) receptor agonists are medications licensed in the UK for managing type 2 diabetes and, in some cases, obesity

doi:10.1016/S0736-0266(03)00110-4 Goldstein AL, Hannappel E, Sosne G, Kleinman HK